Adriamycin CS

Adriamycin CS Adverse Reactions





Zuellig Pharma


Full Prescribing Info
Adverse Reactions
Adverse reactions reported in association with doxorubicin therapy are listed as follows by MedDRA System Organ Class and by frequency. Frequencies are defined as: Very common (≥10%), Common (≥1%, <10%), Uncommon (≥0.1%, <1%), Rare (≥0.01%, <0.1%), Very rare (<0.01%) and Not known (cannot be estimated from available data). (See Table 3.)

Click on icon to see table/diagram/image

Intravesical Use: Systemic toxicity is not a common problem, however, adverse reactions have been noted at doses exceeding that recommended (see DOSAGE & ADMINISTRATION).
Local reactions observed include chemical cystitis, contraction of the bladder, haematuria, painful micturition, frequency and urgency. These disturbances are transient.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in